Mariel Keaney
Affiliation
Research Associate & PhD Candidate
3-in-1 blood pressure pill developed from George Institute research achieves major milestone
Media release
A New Drug Application for GMRx2, a novel low dose triple combination pill for the treatment of hypertension, has been submitted to the US Food and Drug Administration (FDA) by George Medicines following many years of research by The George Institute.